Table 2

Symptomatic nonagenarians

Patient NoMedical historyAnatomical considerationsType of embolic protectionType of stentComplications and/or last clinical follow-up
1Hyperlipidemia, CAD, CKDType III arch, calcified archEPI filter wire, distalWallstentDeath at 4 months
2Hyperlipidemia, HTN, CADType II arch, bovine archAccunet 5,5AcculinkStroke at 16 months, death at 19 months
3Hyperlipidemia, HTN, CAD, AFIB, former smokerTortuous innominateEPI filter wire, distalXactDeath at 9 months
4Hyperlipidemia, HTN, CAD, previous stroke/TIA, former smokerType III arch, tortuous innominateEPI filter wire, distalXactDeath at 23 months
5Hyperlipidemia, HTN, previous stroke/TIAType III arch, bovine archEPI filter wire, distalXactEvent free 67 months follow-up
6Previous stroke/TIAType III arch, tortuous innominateEPI filter wire, distalXactStroke within 30 days, no other events, 52 months follow-up
7HTNNoneEPI filter wire, distalXactDeath at 21 months
8HTN, DM 2, CAD, former smokerType II arch, tortuous innominateEZ filter, distalWallstentDeath within 30 days
9HTN, previous stroke/TIA, former smoker, CKDNoneEZ filter, distalWallstentEvent free 17 months follow-up
10Hyperlipidemia, HTN, DM 2, AFIBType II archMo.Ma, proximalWallstentEvent free 12 months follow-up
11Hyperlipidemia, HTN, former smokerType III archMo.Ma, proximalWallstentEvent free 10 months follow-up
  • Cases are listed in chronological order of the date on which the procedure was performed.

  • Column 6 is the time measured from the day of procedure postoperatively to the last follow-up or to an event. There were no complications unless otherwise stated.

  • Previous ischemic stroke/TIA indicates a past history of ischemic events before the intervention in this study was performed.

  • Manufacturers: Accunet, Abbott Vascular, Redwood City, California, USA; EPI filter, Boston Scientific, Natick, Massachusetts, USA; EZ filter, Boston Scientific; Mo.Ma, Invatec, Roncadelle Brescia, Italy; Wallstent, Boston Scientific; Xact, Abbott Vascular.

  • AFIB, atrial fibrillation; CAD, coronary artery disease; CKD, chronic kidney disease; DM 2, diabetes mellitus type 2; HTN, hypertension; TIA, transient ischemic attack.